Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma

Fig. 2

The unsupervised based on the acetylation-related genes were associated with the recurrence and immune infiltration profiles of early-stage LUAD. A The early-stage LUAD patients were divided into two groups according to the consensus clustering algorithm. B The clustering was associated with the recurrence-free survival rate of early-stage LUAD patients. C The tumor of early-stage LUAD patients in C2 was more likely to relapse. D The immune cell infiltration levels calculated by TIMER and CIBERSORT algorithms in C1 and C2 patients. LUAD lung adenocarcinoma, C1 Cluster 1, C2 Cluster 2; *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us